Ricevi le ultime notizie sulle azioni ADC Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ADCT

Ultime notizie per

ADC Therapeutics

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

ADC Therapeutics SA

Press Releases

ADC Therapeutics Announces $100 Million Private Placement Extending Expected Cash Runway into 2028

ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

Small Cap

Opinion

The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?

ADC Therapeutics Makes Grant to New Employee Under Inducement Plan

Mutual Funds

Markets

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025

Earnings

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025

ADCT

CTOR

ONCY

OSTX

TEVA

TEVJF

TSX:ONC

Astria Therapeutics

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Corvus Pharmaceuticals, Inc. - Common Stock

Corvus Pharma

CytomX Therapeutics

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Emergent BioSolutions

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Monte Rosa Therapeutics, Inc. - Common Stock

Monte Rosa Therapeutics

Gossamer Bio

Inhibrx Biosciences

Korro Bio

Lexeo Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Ocugen

Organogenesis Holdings

ProKidney Corp. - Class A Ordinary Shares

ProKidney

Prothena Corporation plc - Ordinary Shares

Prothena Corp

RAPT Therapeutics

Rigel Pharmaceuticals, Inc. - Common Stock

Comments

ADC Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO